CP
CLBT icon

Clayton Partners’s Cellebrite CLBT Stock Holding History

Clayton Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100,423
Closed -$1.61M – 38
2025
Q2 		$1.61M Sell
100,423
-10,456
-9% -$186K 1.35% 27
2025
Q1 		$2.15M Sell
110,879
-15,205
-12% -$320K 1.87% 27
2024
Q4 		$2.78M Sell
126,084
-538
-0.4% -$10.4K 1.92% 22
2024
Q3 		$2.13M Buy
+126,622
New +$1.88M 1.54% 29

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Clayton Partners's CLBT Position: Q3 2025 in Review

Clayton Partners sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 100,423 shares — an estimated $1.61M sold.

Clayton Partners first reported a position in CLBT in Q3 2024 and held it in 4 quarters. The position peaked at $2.78M in Q4 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Clayton Partners reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Clayton Partners sold 100,423 Cellebrite shares in Q3 2025, an estimated $1.61M.
  • Clayton Partners first reported a position in Cellebrite in Q3 2024 and held it in 4 quarters.
  • Clayton Partners's Cellebrite position peaked at $2.78M in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Clayton Partners's 13F filing for Q3 2025, filed 10 Nov 2025.